Medical Journals

Immunotherapy of Hepatoma with a Monoclonal Antibody Against Murine Endoglin.

Authors:
  • Tan Guang-Hong
  • Huang Feng-Ying
  • Wang Hua
  • Huang Yong-Hao
  • Lin Ying-Ying
  • Li Yue-Nan

From: Hainan Provincial Key Laboratory of Tropical Medicine, Hainan Medical College, Haikou 571101, Hainan Province, China. tanhoho@163.com

World journal of gastroenterology : WJG

  • Publish Date: May 2007
  • ISSN: 1007-9327
  • Volume: 13
  • Issue: 17
  • Pages: 2479-83
  • Medium: Print
  • Language: English
  • Citation (JAMA): Tan Guang-Hong, Huang Feng-Ying, Wang Hua, et al. Immunotherapy of Hepatoma with a Monoclonal Antibody Against Murine Endoglin.. World J. Gastroenterol. May 2007;13:2479-83

Abstract

AIM: To explore the capability of a monoclonal antibody (mAb) against murine endoglin to inhibit tumor angiogenesis and suppression of hepatoma growth in murine models. METHODS: A monoclonal antibody against murine endoglin was purified by affinity chromatography and passively transfused through tail veins in two murine hepatoma models. Tumor volume and survival time were observed at three-day intervals for 48 d. Microvessels in tumor tissues were detected by immunohistochemistry against CD31, and angiogenesis in vivo was determined by alginate encapsulated assay. In addition, tumor cell apoptosis was detected by TUNEL assay. RESULTS: Passive immunotherapy with anti-endoglin mAb could effectively suppress tumor growth, and prolonged the survival time of hepatoma-bearing mice. Angiogenesis was apparently inhibited within the tumor tissues, and the vascularization of alginate beads was also reduced in the mice passively transfused with anti-endoglin mAb. In addition, increased apoptotic cells were observed within the tumor tissues from the mice passively transfused with anti-endoglin mAb. CONCLUSION: Passive immunotherapy with anti-endoglin mAb effectively inhibits tumor growth via inhibiting tumor angiogenesis and increasing tumor cell apoptosis, which may be highly correlated with the blockage of endoglin-related signal pathway induced by anti-endoglin mAb.

Mesh Headings (Keywords): Alginates, Animals, Antibodies, Monoclonal, Apoptosis, Cell Line, Tumor, Disease Models, Animal, Glucuronic Acid, Hexuronic Acids, Immunization, Passive, Intracellular Signaling Peptides and Proteins, Liver Neoplasms, Experimental, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Nude, Microspheres, Neovascularization, Pathologic, Random Allocation, Signal Transduction, Survival Rate


Check for Full Text / PubMed Unique Identifier (PMID): 17552032


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.